Updates in the Diagnosis and Treatment of Castleman Disease: Expert Perspectives
Women’s Health Prime TimeTM: Using Telemedicine to Increase Access to Long-Acting Reversible Contraception (LARC)
Release Date: November 6, 2020
Last Reviewed: November 5, 2020
Expiration Date: November 6, 2021
Time to Complete Activity: 0.75 hour
*This activity expired for credit on November 6, 2021 and is no longer available for credit
Faculty
Nathaniel DeNicola, MD, MSHP (Chair)
Assistant Professor of Obstetrics and Gynecology
Chair of Telehealth
American College of Obstetricians and Gynecologists
Johns Hopkins Medicine
Washington, DC
Christine Dehlendorf, MD
Vice Chair for Research, Family and Community Medicine
Director, Person-Centered Reproductive Health Program
Professor
Departments of Family and Community Medicine; Obstetrics, Gynecology and Reproductive Sciences, Epidemiology and Biostatistics
University of California, San Francisco
San Francisco, CA
Terri-Ann Thompson, PhD
Senior Associate
Ibis Reproductive Health
Cambridge, MA
This activity is provided by Paradigm Medical Communications, LLC.
Disclosure of Commercial Support
This activity is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
Target Audience
This activity has been designed to address the educational needs of primary care clinicians, obstetrician-gynecologists (OB/GYNs), as well as nurse practitioners (NPs) and PAs who provide healthcare for reproductive-aged women.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
- Describe the workflow and currently available best practices to deliver women’s healthcare via telemedicine
- Summarize a patient-centered approach to effective contraceptive counseling via telemedicine, including non-contraceptive benefits of different methods and eligibility criteria for patients who desire a LARC method
- Formulate effective, evidence-based strategies to reduce barriers to LARC access, focusing on decreasing the number of in-office visits for LARC initiation and telesupport follow up
Agenda
- Welcome and Introductions
- Telemedicine: Past, Present, and Future
- Contraception Via Telehealth
- Focus on Telehealth and LARC
- Future Directions: A Hybrid Model of Contraception Care?
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 0.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Instructions for Participation
To receive a CME certificate of participation, you should:
- Follow instructions to register or log in with your professional information and complete the pre-activity assessment
- View the online activity in its entirety
- Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest
For questions regarding CME credit, contact the Paradigm CME Department at cme@paradigmmc.com or (845) 398-5949.
There is no fee required for participation in this activity.
Hardware/Software Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+
PDF documents
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here: http://get.adobe.com/reader
Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.
Disclosures
In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Nathaniel DeNicola, MD, MSHP (Chair)
Has no financial relationships to disclose.
Christine Dehlendorf, MD
Has no financial relationships to disclose.
Terri-Ann Thompson, PhD
Has no financial relationships to disclose.
Independent peer reviewer has no financial relationships to disclose.
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.
Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC’s activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
© 2020 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.